<DOC>
	<DOC>NCT01930786</DOC>
	<brief_summary>This is a registry study in adults with spasticity to determine onabotulinumtoxinA use in clinical practice. Treatment will be administered in accordance with physician standard practice. All treatment decisions lie with the physician.</brief_summary>
	<brief_title>An Adult Spasticity Registry of OnabotulinumtoxinA Treatment</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Treatment with onabotulinumtoxinA according to the decision of the physician for spasticity Willingness to complete study questionnaires and answer study questions by phone or internet Concurrent participation in a clinical trial for spasticity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>